Whoa! These 3 Stocks Are Outpacing the Dow’s Run: Research In Motion Ltd (BBRY), MannKind Corporation (MNKD), Dex One Corporation (DEXO)

But analysts don’t think much of the takeover talk, at least not in the near term, if for no other reason than the Canadian government might look askance at it. That leaves BlackBerry having to fend for itself with its new models, which isn’t so bad considering T-Mobile is releasing the Z10 to business customers in a week or so. While Verizon Communications Inc. (NYSE:VZ) hasn’t said when it will offer the phone, the bar for expectations has been set so low for BlackBerry that analysts believe any gains it achieves will be seen as a huge success.

That’s just nutty
Like Dex One Corporation (NYSE:DEXO), biotech MannKind Corporation (NASDAQ:MNKD) surged on no apparent news yesterday, and though it’s short interest ratio is an elevated 13.5 days to cover, it seems unlikely that was driving the stock higher as it often has double-digit short ratio.

Analysts at Wells Fargo & Co (NYSE:WFC), though, reaffirmed their “market perform” rating but did so in that backhanded way people will do when they’re actually criticizing you. Even though the analyst likes the market potential MannKind’s inhaled insulin therapy Afrezza holds, he believes “the stock requires too much patience and risk tolerance to recommend buying shares at this time.”

Well, analysts who make their living on you trading your account would never want to recommend patience, now would they? Risk is a different matter though as the FDA could always shoot down the treatment or its substantial debt burden could ultimately crush the company. But as I noted last fall, I believe MannKind will not only survive but thrive. I think the biotech has proven Afrezza is viable and that sooner rather than later a partner will emerge to help carry the load. I rated MannKind Corporation (NASDAQ:MNKD) on Motley Fool CAPS last October to outperform the broad indexes, and it’s gained 80% since then compared to a 10% rise in the S&P 500, so let me know in the comments box below if you agree MannKind Corporation (NASDAQ:MNKD) will prove those with patience are the smarter investors.

The article Whoa! These 3 Stocks Are Outpacing the Dow’s Run originally appeared on Fool.com and is written by Rich Duprey.

Fool contributor Rich Duprey has no position in any stocks mentioned. The Motley Fool recommends Wells Fargo. The Motley Fool owns shares of Wells Fargo.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.